WE AIM TO BE A RESEARCH & DEVELOPMENT (“R&D”) INNOVATION ENGINE THAT DISCOVERS, DEVELOPS AND ULTIMATELY DELIVERS IMPACTFUL MEDICINES TO PATIENTS
We operate as a clinical-stage pharmaceutical company with a Research & Development (“R&D”) innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients. We seek to pursue the best assets in a capital efficient manner with objective and strategic decision-making to rapidly progress our programs through development. Through our approach, we strive to deliver medicines that can lead to significant impact for patients who are desperately in need of new treatments.
Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology.
Our management team has extensive R&D experience, and provides direct guidance to our program teams as they advance candidates from research through all stages of development.